Background <p><i>Mycobacterium shinjukuense</i> is a rare type of non-tuberculous mycobacterium (NTM) first reported in Japan. Reported cases of Mycobacterium shinjukuense pulmonary diseases are rare where hosts exhibited apparent risk factors for NTM infection. No consensus has been made on its treatment regimen.</p> Case presentation <p>We report a case of <i>Mycobacterium shinjukuense </i>pulmonary disease in a previously healthy young woman presented as focal bronchiectasis and nodules. The diagnosis was established with <i>16S</i> rRNA sequencing on bronchoalveolar lavage fluid mycobacterium culture. The patient was successfully treated with a thrice-a-week regimen of azithromycin, isoniazid and rifampicin. Whole-exome sequencing revealed mutations in <i>TNFRSF13B </i>and <i>TLR2</i>.</p> Conclusion <p>The presence of <i>Mycobacterium shinjukuense</i> pulmonary disease was confirmed in China. Macrolide, rifampicin and isoniazid was effective in treatment of <i>Mycobacterium shinjukuense</i> pulmonary disease. Genetic susceptibility to NTM should be considered in young patients without apparent risk factors</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Mycobacterium shinjukuense pulmonary disease in a young woman: a case report and literature review

  • Siwei Gu,
  • Chunlei Wang,
  • Binghuai Lu,
  • Xiaojing Cui

摘要

Background

Mycobacterium shinjukuense is a rare type of non-tuberculous mycobacterium (NTM) first reported in Japan. Reported cases of Mycobacterium shinjukuense pulmonary diseases are rare where hosts exhibited apparent risk factors for NTM infection. No consensus has been made on its treatment regimen.

Case presentation

We report a case of Mycobacterium shinjukuense pulmonary disease in a previously healthy young woman presented as focal bronchiectasis and nodules. The diagnosis was established with 16S rRNA sequencing on bronchoalveolar lavage fluid mycobacterium culture. The patient was successfully treated with a thrice-a-week regimen of azithromycin, isoniazid and rifampicin. Whole-exome sequencing revealed mutations in TNFRSF13B and TLR2.

Conclusion

The presence of Mycobacterium shinjukuense pulmonary disease was confirmed in China. Macrolide, rifampicin and isoniazid was effective in treatment of Mycobacterium shinjukuense pulmonary disease. Genetic susceptibility to NTM should be considered in young patients without apparent risk factors